AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma ...
People with severe asthma insured by BlueCross BlueShield of Illinois may soon face a new hurdle in accessing a treatment ...
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
Independent Advisor Alliance increased its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 13.0% in the fourth ...
Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used benralizumab, according to a poster presented here. Lower blood eosinophil counts ...
More than 50% of patients with severe asthma have high eosinophil levels, making them candidates for biologic therapies like Nucala and other drugs like AstraZeneca’s Fasenra (benralizumab ...
The area’s finest competitors showed off their pickleball skills at the Carvana PPA tour CIBC Texas Open at the Courts of ...
Asthma is a chronic condition that affects the airways in your lungs. It makes the airways inflamed and swollen, causing symptoms like coughing and wheezing. Exercise may help ease asthma symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback